Artículos por temáticas

The relation between proprioceptive ability and physical function in people with stroke, Parkinson's disease, and multiple sclerosis: a systematic review

Robertson LS, Fisher G, Diong J, Butler AA, Gandevia SC, Héroux ME.

J Appl Physiol (1985). 2025 Jul 1;139(1):167-184. doi: 10.1152/japplphysiol.00088.2025. Epub 2025 Jun 5.

Effectiveness of telerehabilitation in reducing motor disability and enhancing quality of life in parkinson's disease: a systematic review and meta-analysis

Nourelden AZ, Mamdouh M, Kamal I, Ahmed OKA, Elwahab ARA, Elkholy M, Tawfik AG, Gamal MH, Fathallah AH.

Acta Neurol Belg. 2025 Jul 16. doi: 10.1007/s13760-025-02838-4. Online ahead of print.

Translating Exosomal microRNAs from Bench to Bedside in Parkinson's Disease

Arias-Carrión O, Reyes-Mata MP, Zúñiga J, Ortuño-Sahagún D.

Brain Sci. 2025 Jul 16;15(7):756. doi: 10.3390/brainsci15070756.

Unraveling the mystery: How autophagy deficiency in dopaminergic neurons drives human Parkinson's disease

Noda S, Hattori N.

Mol Brain. 2025 Jul 24;18(1):66. doi: 10.1186/s13041-025-01235-5.

Proposed biological definitions of Parkinson's disease confuse understanding without delivering meaningful advances

Cardoso F, Schmidt P.

J Parkinsons Dis. 2025 Aug;15(5):939-943. doi: 10.1177/1877718X241308482. Epub 2025 Jan 14.

Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders

Zhang Y, Zhang T, Zhao M, Li P, Liu T, Xie J.

Front Pharmacol. 2025 Jul 16;16:1618623. doi: 10.3389/fphar.2025.1618623. eCollection 2025.

Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson's disease

Ross A, Prowse N, Zhang H, Hayley S, Sun H.

Front Cell Neurosci. 2025 Jul 18;19:1627305. doi: 10.3389/fncel.2025.1627305. eCollection 2025.

Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment

Zang Z, Yang F, Qu L, Ge M, Tong L, Xue L, Sun X, Hai Y.

Front Aging Neurosci. 2025 Aug 7;17:1640389. doi: 10.3389/fnagi.2025.1640389. eCollection 2025.

Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's disease

O'Callaghan C, Hezemans FH, Subramaniam N, Ye R, Tsvetanov KA, Murley AG, Holland N, Orlando IF, Regenthal R, Barker RA, Williams-Gray CH, Passamonti L, Robbins TW, Rowe JB.

Commun Biol. 2025 Aug 14;8(1):1223. doi: 10.1038/s42003-025-08627-2.

Tics and Parkinson's Disease: Clinical and Pathophysiological Insights from a Rare Syndromic Association

Abkur T, Boogers A, Grippe T, Isaacs DA, Malaty IA, Munhoz RP, Bhatia KP, Hart LA, Fasano A, Kalia S, Lang AE, Ganos C.

Mov Disord Clin Pract. 2025 Aug;12(8):1173-1180. doi: 10.1002/mdc3.70111. Epub 2025 Apr 30.

Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy

Sharma G, Wadhwa K, Kumar S, Singh G, Pahwa R.

Drug Deliv Transl Res. 2025 Aug;15(8):2589-2607. doi: 10.1007/s13346-024-01770-z. Epub 2025 Jan 8.

Role and regulatory mechanism of GPR37 in neurological diseases

Liu S, Bai T, Liu X, Zhao W, Li X, Sui Y, Feng J.

Front Cell Neurosci. 2025 Jul 31;19:1617682. doi: 10.3389/fncel.2025.1617682. eCollection 2025.

Recent advances in the genetics of Parkinson's disease in underrepresented populations

Marconi GA, Teixeira-Dos-Santos D, Schuh AFS.

Curr Opin Neurol. 2025 Aug 1;38(4):349-354. doi: 10.1097/WCO.0000000000001391. Epub 2025 Jun 5.

Understanding pain in Parkinson's disease: types, predictors, and treatment approaches

Toledo JPC.

Korean J Pain. 2025 Jul 1;38(3):355-356. doi: 10.3344/kjp.25015. Epub 2025 Jun 10.

Reliability and validity of in-home tele-neuropsychological testing in patients with Parkinson's disease: A randomized trial

Sperling SA, Dong J, Lapin B, Li Y.

Clin Neuropsychol. 2025 Jul;39(5):1119-1154. doi: 10.1080/13854046.2025.2503374. Epub 2025 May 16.